Press release
Antihypertensive Drugs Market Size To Reach US$ 34.9 Billion by 2028
The IMARC Group provides extensive analysis of the "Antihypertensive Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", the global antihypertensive drugs market size reached US$ 28.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 34.9 Billion by 2028, exhibiting a growth rate (CAGR) of 3.1% during 2023-2028.Antihypertensive Drugs Market Growth and Demand:
The antihypertensive drugs market is driven by the increasing prevalence of hypertension among the masses. Additionally, the growing awareness of the importance of cardiovascular health is influencing the antihypertensive drugs market. Public health campaigns and educational initiatives have emphasized the significance of blood pressure control in reducing the risk of heart disease, stroke, and other cardiovascular disorders.
Furthermore, continual advancements in research and development are supporting the market as pharmaceutical companies are heavily investing in the development of innovative drugs that provide better efficacy, fewer side effects, and improved patient compliance. Other factors, such as the expansion of telemedicine and e-Health applications and extensive research and development (R&D) activities, also contribute to the market.
Get Sample Copy of Report at : https://www.imarcgroup.com/antihypertensive-drugs-market/requestsample
Competitive Landscape with Key Players:
• AstraZeneca
• Boehringer Ingelheim International GmbH
• Daiichi Sankyo Company Limited
• Johnson & Johnson Services Inc.
• Lupin Pharmaceuticals Inc
• Merck & Co. Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi and Sun Pharmaceutical Industries Ltd.
Antihypertensive Drugs Trends:
Hypertension is a chronic condition that significantly increases the risk of cardiovascular diseases, stroke, and other related health complications. Antihypertensive drugs are therapeutic medications utilized for the prevention, control, and treatment of hypertension and high blood pressure disorders. These drugs include alpha-blockers, diuretics, angiotensin-converting enzyme (ACE) inhibitors, Renin Inhibitors, Angiotensin II receptor blockers, and calcium channel blockers.
They work by reducing blood pressure, eliminating excess fluid and salt from the body, and helping to relax and widen blood vessels or slow down the heart rate. Antihypertensive drugs can be administered orally or through intravenous injections and have wide usage in hospitals, clinics, rehabilitation centers, and ambulatory surgical centers.
Browse Full Report With TOC: https://www.imarcgroup.com/antihypertensive-drugs-market
Key Market Segmentation:
Breakup by Therapeutic Class:
• Diuretics
• ACE Inhibitors
• Calcium Channel Blockers
• Beta-adrenergic Blockers
• Vasodilators
• Others
Breakup by Type:
• Primary hypertension
• Secondary Hypertension
Breakup by Distribution Channel:
• Retail Pharmacy
• Hospital Pharmacy
• E-Commerce
Breakup by Region:
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antihypertensive Drugs Market Size To Reach US$ 34.9 Billion by 2028 here
News-ID: 3317935 • Views: …
More Releases from IMARC Group
Australia Truck Market Projected to Reach USD 280.91 Million by 2033
Market Overview
The Australia truck market size was valued at USD 150.00 Million in 2024 and is projected to reach USD 280.91 Million by 2033. This growth is fueled by increasing demand in freight and logistics, sustainability initiatives, government infrastructure investments, and technological advancements. Fleet operators are progressively adopting cleaner and more efficient trucks to meet regulations and environmental expectations. Key trends include electrification, autonomous vehicle technology, and advanced safety systems.…
Australia Patient Handling Equipment Market Projected to Reach USD 451.29 Millio …
Market Overview
The Australia patient handling equipment market was valued at USD 263.87 Million in 2025 and is expected to reach USD 451.29 Million by 2034, growing at a compound annual growth rate of 6.14% during the forecast period of 2026-2034. Expansion is driven by an aging population needing specialized mobility and care, government funding for aged care modernization, and increased focus on workplace safety to reduce caregiver injuries. Technological advancements…
Australia Fermented Superfoods Market Projected to Reach USD 1,515.2 Million by …
Market Overview
The Australia fermented superfoods market attained a size of USD 715.2 Million in 2024 and is forecasted to grow to USD 1,515.2 Million by 2033. The market is expected to achieve this expansion over the forecast period from 2025 to 2033 at a compound annual growth rate of 8.7%. Growth is driven by the rising consumer awareness of gut health and demand for organic, locally sourced ingredients alongside continuous…
Mexico Mixed Xylene Market Size, Growth, Latest Trends and Forecast 2026-2034
IMARC Group has recently released a new research study titled "Mexico Mixed Xylene Market Size, Share, Trends and Forecast by Grade, End Use, and Region, 2026-2034" which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.
Market Overview
The Mexico mixed xylene market size was valued at USD 924.83 Million in 2025 and is projected to reach USD…
More Releases for Antihypertensive
Antihypertensive Drugs Market Future Prediction Report By 2033
The global Antihypertensive Drugs Market was valued at approximately USD 30.5 billion in 2024 and is projected to reach around USD 38.4 billion by 2033, growing at a compound annual growth rate (CAGR) of 2.6% from 2025 to 2033 .
Antihypertensive Drugs Market Overview
The global Antihypertensive Drugs Marke is driven by the rising global burden of hypertension, especially among the elderly and individuals with lifestyle-related risk factors such as obesity, poor…
Antihypertensive Drugs Market Segmentation, and Future Growth Prospects
In recent years, the global Antihypertensive Drugs Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Antihypertensive Drugs Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including Porters Five…
Antihypertensive Drugs Market Size to Reach USD 10 Billion 2030
Exclusive Report by Ameco Research: Antihypertensive Drugs Market Size Projected to Reach USD 52 Billion by 2030, Growing at 4.70% CAGR
Ameco Research is proud to announce the launch of its latest market research report, Antihypertensive Drugs Market. This comprehensive report provides in-depth analysis and insights into the current market trends and future projections in the Industry/Market Segment. Ameco Research has been at the forefront of providing quality market research…
Antihypertensive Drugs Market to Develop Rapidly by 2031, TMR Study
The global Antihypertensive Drugs Market market is estimated to attain a valuation of US$ 40 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 3% during the forecast period, 2022 to 2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major…
Global Antihypertensive Drugs Market Study Analysis: Hypertension is becoming ev …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 4.87% during the forecast period. Hypertension is a medical condition that results in a rise in blood pressure in the arteries. Hypertension may lead to numerous serious complications including heart failure, aneurysm, heart attacks, and dementia. To prevent the serious effects of hypertension early diagnosis…
Safety And Effectiveness Of First-line Antihypertensive Drug Classes
For those with extremely high blood pressure, or hypertension, there are many initial medication options -- so many that it can be hard to know which one to use. Now, a Yale-coauthored paper in Lancet provides more information about the relative safety and effectiveness of different hypertension drugs in order to inform this critical treatment decision. The study reveals that angiotensin converting enzyme (ACE) inhibitors may not be the best…
